| 51 | 16078846 | Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure-activity relationship, and evaluation of benzofuran derivatives. | J Med Chem | 2005 Aug 11 |
3 |
| 52 | 16271145 | A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor. | BMC Biochem | 2005 Nov 4 |
3 |
| 53 | 16297632 | Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists. | Bioorg Med Chem | 2006 Mar 15 |
1 |
| 54 | 16672356 | Developmental regulation of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period. | Reproduction | 2006 May |
2 |
| 55 | 16723294 | Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension. | Eur J Med Res | 2006 May 5 |
2 |
| 56 | 16880763 | Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations. | Br J Pharmacol | 2006 Sep |
2 |
| 57 | 16885208 | Adenylyl cyclase 6 overexpression decreases the permeability of endothelial monolayers via preferential enhancement of prostacyclin receptor function. | Mol Pharmacol | 2006 Nov |
1 |
| 58 | 16942748 | Characterization of the molecular mechanisms of the coupling between intracellular loops of prostacyclin receptor with the C-terminal domain of the Galphas protein in human coronary artery smooth muscle cells. | Arch Biochem Biophys | 2006 Oct 1 |
1 |
| 59 | 17015447 | Versatility and differential roles of cysteine residues in human prostacyclin receptor structure and function. | J Biol Chem | 2006 Dec 1 |
3 |
| 60 | 17106906 | Asymmetric synthesis of 3-oxa-15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin and its neuroprotective analogue 15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin based on the conjugate addition-azoalkene-asymmetric olefination strategy. | Chemistry | 2007 |
1 |
| 61 | 17123841 | BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13. | Osteoarthritis Cartilage | 2007 Apr |
1 |
| 62 | 17239589 | Discovery and preliminary evaluation of 5-(4-phenylbenzyl)oxazole-4-carboxamides as prostacyclin receptor antagonists. | Bioorg Med Chem Lett | 2007 Mar 1 |
1 |
| 63 | 17496729 | Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. | Pharmacogenet Genomics | 2007 Apr |
2 |
| 64 | 17764960 | Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists. | Bioorg Med Chem | 2007 Nov 1 |
2 |
| 65 | 17920266 | Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists. | Bioorg Med Chem Lett | 2007 Dec 1 |
2 |
| 66 | 18221089 | TP receptor as a therapeutic target in atherosclerosis and related cardiovascular diseases. | Recent Pat Cardiovasc Drug Discov | 2006 Nov |
1 |
| 67 | 18323528 | Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. | Circ Res | 2008 Apr 25 |
1 |
| 68 | 18511850 | Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells. | Circ Res | 2008 Jul 3 |
1 |
| 69 | 19033666 | Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. | J Clin Invest | 2008 Dec |
1 |
| 70 | 19302827 | Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation. | J Mol Cell Cardiol | 2009 May |
3 |
| 71 | 19880449 | Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells. | J Immunol | 2009 Nov 15 |
2 |
| 72 | 20085435 | Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system. | Platelets | 2010 |
1 |
| 73 | 20522800 | Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease. | Arterioscler Thromb Vasc Biol | 2010 Sep |
2 |
| 74 | 20631411 | Regulation of cAMP by phosphodiesterases in erythrocytes. | Pharmacol Rep | 2010 May-Jun |
2 |
| 75 | 21606930 | Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury. | Spinal Cord | 2011 Aug |
2 |
| 76 | 22159995 | Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel. | Am J Physiol Heart Circ Physiol | 2012 Feb 1 |
1 |
| 77 | 22362844 | Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. | Eur Respir J | 2012 Oct |
1 |
| 78 | 22480736 | Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. | Biochem Pharmacol | 2012 Jul 1 |
3 |
| 79 | 22969152 | Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1. | J Lipid Res | 2012 Nov |
5 |
| 80 | 23109431 | New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling. | Mol Cell Biol | 2013 Jan |
1 |
| 81 | 23457445 | Molecular analysis of the prostacyclin receptor's interaction with the PDZ1 domain of its adaptor protein PDZK1. | PLoS One | 2013 |
1 |
| 82 | 24392948 | Selexipag for the treatment of pulmonary arterial hypertension. | Expert Opin Pharmacother | 2014 Feb |
1 |
| 83 | 24450852 | Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis. | Antioxid Redox Signal | 2014 Jun 10 |
1 |
| 84 | 24682422 | Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. | Naunyn Schmiedebergs Arch Pharmacol | 2014 May |
1 |
| 85 | 24954635 | Expression profile and role of prostacyclin receptor (PTGIR) in peri-implantation porcine conceptuses. | Theriogenology | 2014 Sep 1 |
2 |
| 86 | 25082887 | Beraprost sodium, a stable prostacyclin analogue, elicits dilation of isolated porcine retinal arterioles: roles of eNOS and potassium channels. | Invest Ophthalmol Vis Sci | 2014 Jul 31 |
2 |
| 87 | 25277144 | Multiple-dose up-titration study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of selexipag, an orally available selective prostacyclin receptor agonist, in healthy subjects. | Pharmacology | 2014 |
1 |
| 88 | 25617843 | Prostacyclin receptor expression on platelets of humans with type 2 diabetes is inversely correlated with hemoglobin A1c levels. | Prostaglandins Other Lipid Mediat | 2015 Jan-Mar |
1 |
| 89 | 25850750 | Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag. | Am J Cardiovasc Drugs | 2015 Jun |
1 |
| 90 | 25851691 | Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects. | Br J Clin Pharmacol | 2015 Oct |
1 |
| 91 | 25936507 | Prostacyclin receptors: Transcriptional regulation and novel signalling mechanisms. | Prostaglandins Other Lipid Mediat | 2015 Sep |
1 |
| 92 | 26139576 | Prostacyclin receptor (PTGIR) in the porcine endometrium: Regulation of expression and role in luminal epithelial and stromal cells. | Theriogenology | 2015 Oct 1 |
2 |
| 93 | 26152132 | Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study. | Int J Clin Pharmacol Ther | 2015 Sep |
2 |
| 94 | 26261823 | Expression of prostaglandin I2 (prostacyclin) receptor in blood of migraine patients: A potential biomarker. | Adv Biomed Res | 2015 |
1 |
| 95 | 26269890 | Cytoprotective Role of Prostaglandin D<sub>2</sub> DP1 Receptor against Neuronal Injury Following Acute Excitotoxicity and Cerebral Ischemia | | 2015 |
2 |
| 96 | 26291199 | Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. | J Med Chem | 2015 Sep 24 |
2 |
| 97 | 26846322 | Selexipag: First Global Approval. | Drugs | 2016 Mar |
1 |
| 98 | 26946143 | Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes. | Cytotechnology | 2016 Dec |
2 |
| 99 | 27062188 | Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment. | Br J Clin Pharmacol | 2016 Aug |
2 |
| 100 | 27063071 | Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects. | Clin Ther | 2016 May |
1 |